Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

PFE 23.94 +0.12 (0.50%)
price chart
Pfizer Inc Declares Third-Quarter 2012 Dividend
Reuters Key Development - Jun 28, 2012
Nestle SA In Talks For EUR7 Billion Acquisition Loan To Help Fund $11.85 Billion Takeover Of Pfizer, Inc.'s Nutrition-Reuters
Reuters Key Development - Jun 28, 2012
Breckenridge and Alembic Pharmaceuticals Limited Announce Paragraph IV ANDA Litigation with Pfizer Inc on Desvenlafaxine Tablets (Pristiq)
Reuters Key Development - Jun 28, 2012
Bristol-Myers Squibb Co And Pfizer, Inc. Receives Complete Response Letter From U.S. Food And Drug Administration For ELIQUIS (apixaban)
Reuters Key Development - Jun 25, 2012
European Medicines Agency Committee For Medicinal Products For Human Use Adopts Opinion On Pfizer Inc And Protalix BioTherapeutics, Inc.'s Taliglucerase Alfa Marketing Authorization Application
Reuters Key Development - Jun 22, 2012
Pfizer Inc Announces FDA Approved Lyrica
Reuters Key Development - Jun 21, 2012
Pfizer Inc Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating XALKORI In Previously Treated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer
Reuters Key Development - Jun 19, 2012
FDA Seeks More Data On Pfizer Inc Rare Disease Drug-Reuters
Reuters Key Development - Jun 18, 2012
Takeda Pharmaceutical Company Limited To Stop Selling 13 Pfizer, Inc. Drugs In Japan-Reuters
Reuters Key Development - Jun 18, 2012
CVS Caremark Corporation, Rite Aid Corporation Sue Pfizer Inc And Teva Pharmaceutical Industries Ltd Over Depression Drug-Reuters
Reuters Key Development - Jun 12, 2012
Google Finance Beta available in: Hong Kong - Canada - U.S. - China - U.K.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
To see all exchange delays, please see disclaimer.

©2012 Google - Google Home - Blog - Help - Report a Problem - Privacy Policy - Terms of Service